Gland B2B Business Model and Growth Strategy
Injectables: One of the Largest and Fastest Growing Segment
19
1
Injectable formulations is the fastest growing segment in global pharmaceuticals, recording a 2014-2019 CAGR of
10.1% vs overall pharma market at 5.8%
Growth
Opportunity
Global generic injectables market is estimated at c.US$131bn growing at a 2014-19 CAGR of c. 8%
US the largest market (i.e. c. 33-34% of market) is expected to grow at a c.16% CAGR from 2019-2024E
c.US$61.3bn in injectable brand sales expected to lose patent protection between 2020-24 (vs c. US$33bn in sales which
lost patent protection lost between 2014-19)
2
Growth Drivers for
Injectables
Rising prevalence of chronic diseases
Convenience and benefits of New Drug Delivery Systems ("NDDS")
New market opportunities
Drug shortages in the US – from 2014 to 2019 c. 40-60% of the shortages have been in injectables space
3
Market Entry
Barriers
High capital investments
Manufacturing complexities to meet stringent quality standards
High level of compliance and regulatory requirements
Consolidation trend expected to favour established players
Source: IQVIA Report.
GLANDView entire presentation